Advertisement
Advertisement
TAK
Takeda Pharmaceutical Company Limited - ADR
18.68
USDSponsored
-0.05
-0.27%
Oct 12, 15:59 UTC -4
Closed
After-Market
18.20
-0.48
-2.56%
TAK Earnings Reports
Positive Surprise Ratio
TAK beat 29 of 41 last estimates.
71%
Next Report
Date of Next Report
Oct 29, 2026
Estimate for Q2 27 (Revenue/ EPS)
$1.17T
/$46.66
Implied change from Q1 27 (Revenue/ EPS)
-4.45%
/-33.85%
Implied change from Q2 26 (Revenue/ EPS)
+4.74%
/-723.80%
Takeda Pharmaceutical Company Limited - ADR earnings per share and revenue
On Jul 30, 2026, TAK reported earnings of 70.54 USD per share (EPS) for Q1 27, beating the estimate of 54.92 USD, resulting in a 28.43% surprise. Revenue reached 1.22 trillion, compared to an expected 1.16 trillion, with a 5.40% difference. The market reacted with a -2.82% price change (close before vs. close after earnings).
Looking ahead to Q2 27, -- analysts forecast an EPS of 46.66 USD, with revenue projected to reach 1.17 trillion USD, implying an decrease of -33.85% EPS, and decrease of -4.45% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
NanoViricides Inc.
Report Date
Sep 28, 2026 For Q4 26
Estimate
-$0.10
Actual
-$0.10
Surprise
+1.96%
FAQ
What were Takeda Pharmaceutical Company Limited - ADR's earnings and revenue for the latest quarter Q1 2027?
For Q1 2027, Takeda Pharmaceutical Company Limited - ADR reported EPS of $70.54, beating estimates by 28.43%, and revenue of $1.22T, 5.4% above expectations.
How did the market react to Takeda Pharmaceutical Company Limited - ADR's Q1 2027 earnings?
The stock price moved down -2.82%, changed from $17.75 before the earnings release to $17.25 the day after.
When is Takeda Pharmaceutical Company Limited - ADR expected to report next?
The next earning report is scheduled for Oct 29, 2026.
What are the forecasts for Takeda Pharmaceutical Company Limited - ADR's next earnings report?
Based on --
analysts, Takeda Pharmaceutical Company Limited - ADR is expected to report EPS of $46.66 and revenue of $1.17T for Q2 2027.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.